Join to View Full Profile
10510 N 92nd Street Suite 200Scottsdale, AZ 85258
Phone+1 480-323-1350
Dr. Mikhael is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Ottawa Faculty of MedicineClass of 1997
Certifications & Licensure
AZ State Medical License 2007 - 2027
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification FirstNet (Clinical), Cerner Corporation, 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification Access Profiler Enterprise, EMRConnect, 2014-2015, 2017
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2014-2015, 2017
Clinical Trials
- Lenalidomide and Low-Dose Dexamethasone in Patients With Previously Treated Multiple Myeloma and Kidney Dysfunction Start of enrollment: 2009 Jan 21
- Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma Start of enrollment: 2009 Jun 01
- Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide and Planning to Undergo Autologous Stem Cell Transplant Start of enrollment: 2009 Dec 01
Publications & Presentations
PubMed
- Past, Present, and Future of Dexamethasone in Multiple Myeloma and AL Amyloidosis.Rahul Banerjee, Tracy King, Beth Faiman, Susie Harding, Aaron S Rosenberg
Journal of Clinical Oncology. 2026-04-01 - Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.Lisa K Hicks, Hans J Messersmith, Samer Al Hadidi, Rahul Banerjee, Benjamin A Derman
Journal of Clinical Oncology. 2026-04-01 - 4 citationsThe benefits of telehealth in promoting equity in blood cancer care - results of a multi-stakeholder forum and systematic literature review.Joseph Mikhael, Deanna Darlington, Bethany Howell, Jay Hydren, Tricia Hernandez
Journal of Medical Economics. 2025-12-01
Abstracts/Posters
- The Global State of Hematopoietic Stem Cell Transplantation for Multiple Myeloma: An Analysis of the Worldwide Network of Blood and Marrow Transplantation (WBMT) Datab...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- The Relationship between Baseline Biomarkers and Efficacy of Isatuximab in Combination with Pomalidomide and Dexamethasone in RRMM: Insights from Phase 1 and Phase 3 S...Joseph Mikhael, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Predicting Risk of Venous Thromboembolism in Multiple Myeloma: The Impede VTE Score2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Show Me the Money: Negotiating Your First Job60th American Society of Hematology Annual Meeting - 11/30/2018
- Real-world evidence of cardiac hospitalizations in carfilzomib- and non-carfilzomib-treated multiple myeloma patients in the United States.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
Evolving Treatment Landscape Spurs Living Guideline Update on Multiple MyelomaJanuary 6th, 2026- When Is the Best Time to Use CAR T-cell Therapy in Multiple Myeloma?September 23rd, 2025
- Managing Side Effects and Maximizing Quality of Life in Multiple Myeloma PatientsAugust 21st, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
